Express Pharma

JULY 15, 2024

We believe that implementing a fresh PLI scheme for vaccines and biopharmaceutical raw materials is vital now to put the focus back on value-added domestic production with India-for-India and India-for-the-world production. This would stimulate new investments in both R&D and production initiatives.

Medical Records 105

Medical Records Biosimilars Pharmaceutical Companies Pharmaceutical Companies 105

Express Pharma

JANUARY 12, 2024

The government has also introduced schemes to promote medical device parks and bulk drug parks with financial grants across different Indian states. million nurses/midwives in the total stock by 2030. A recent WHO report estimated a shortage of about 1.8 million health workforces in India and suggests that to meet the threshold of 34.5

Insurance Coverage and Processing 52

Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies Health Insurance Companies 52

Express Pharma

NOVEMBER 8, 2024

Vaccines, which typically require years of development, were birthed in a mere 12 months, proving that necessity is the mother of invention, and possibly a rather impatient mother at that. The industry, valued at $220 billion, is expected to reach $300 billion by 2030 and potentially $1 trillion by 2040.

Vaccines 104

Vaccines Communication Online Pharmacies Medical Records 104